Improving the appearance of the skin, especially reducing the signs and symptoms of acne and eczema, are the great benefits of regular CBD oil use. Topical application is quite popular for this, whether in a diluted or undiluted form, depending on the severity of the skin affliction. The powerful anti-inflammatory properties of the oil can also soothe redness, itchiness, and swollen areas of the skin.
As one might expect from the information presented in the previous sections of this article, the position of cannabidiol (both from a medical and from an institutional point of view) is one of uncertainty. To add insult to injury, private companies (especially those targeting immediate profit with a minimum of investment) take advantage of the loopholes in legislation to gain from the media exposure that CBD has had in the past few years.
The immediate and powerful effects of THC are explained because of the special affinity it has with the CB1 type receptors, which mediate crucial processes in the brain. The less prominent (but no less important) action of CBD was explained, at least for a while, by hypothesizing that it binds to CB2 type receptors, hence its more diffuse manner of exercising changes in the body. Early on, the antipsychotic effects of cannabidiol were observed, an aspect which seemed to be in consonance with this initial hypothesis.
The anxiolytic effect of THC is well documented, with other cannabinoids (especially CBD) also providing relief (if less potent). The exact pathways of the process have not been identified. A preliminary study published in 2013 in the International Neuropsychopharmacology Journal has set the foundations for further research linking CBD to future treatments for depression and psychosis.
There has been a fair amount of confusion surrounding the legality of CBD oil. But while the vast majority of cannabinoids are controlled substances under the Misuse of Drugs Act, rest assured that CBD oil is legal across the UK for medicinal purposes, provided it has been derived from an industrial hemp strain that is EU-approved. These strains contain very little to no THC (the psychoactive cannabinoid).
Due to the uniqueness of everyone’s endocannabinoid system, CBD does not affect any two people the same way. There are a host of factors that influence its efficacy, including genetics, previous history of use, general health, weight, ethnicity and so on. Therefore, while one person may find that 15 mg of CBD a day works wonders for suppressing appetite and boosting weight loss, another may require up to 100 mg (or more) in order to achieve the same results (in fact, they may not experience any results at all).
I have read about studies from Europe (not very specific I know) that suggest CBD might work better for some people if combined with some level of THC. Also, the getting high part can be helpful, although not for everybody, of course. A second point – I don’t hear very much about CBD eliminating or almost eliminating pain for people with severe pain. Helpful, but, so far at least, it doesn’t seem that CBDs can replace opioids or substantially reduce pain for all chronic pain patients. Maybe someday.
'If the Patient Information Leaflet that comes with your medication says to avoid grapefruit juice, for instance, then do not take CBD, as the same type of interaction can affect circulating blood levels of your medicine. Even if the leaflet does not mention grapefruit juice, you should still check with your doctor before taking CBD. You should also not take CBD if you are pregnant or breastfeeding.’
Numerous studies have found results that confirm the ability of marijuana to help anxiety and stress. In 2013 an Israeli study demonstrated that treatment with cannabinoids helped to control emotional responses and prevent stress-related responses for those that had experienced a traumatic experience. In 2015 a group of researchers found that cannabis treatments were effective in reducing anxiety in those suffering from PTSD.
It’s believed that while CBD helps activate and regulate the body’s endocannabinoid system, it also helps regulate the neural pathways that are responsible for withdrawal symptoms and drug cravings. In early rat trials, those treated with CBD were less likely to exhibit anxiety-related withdrawal symptoms and drug-seeking behaviors after being exposed to cocaine. (40)
More recent experiments, involving the administration of a part CBD part THC solution, have yielded results that contradict the first supposition. At present, on the evidence that cannabidiol reduces some of the psychoactive effects of tetrahydrocannabinol (acting as a de facto antidepressant), scientists argue that cannabidiol has a holistic but indirect influence on all cannabinoid receptors in the endocannabinoid system. The main consequence of this impact seems to be an increase in the production of endocannabinoids. This is now the prevailing idea that accounts for the mountains of empirical evidence of how the benefits of cannabidiol are expressed at the cellular level.